Fouche Lori Dickerson reported acquisition or exercise transactions in this Form 4 filing.
AEGON LTD. director Lori Dickerson Fouché reported receiving an award of 32 common shares on July 6, 2026. These shares were granted as dividend equivalent shares tied to her outstanding equity awards, rather than purchased on the open market.
After this compensation-related grant, she directly holds a total of 8,966 common shares. The transaction reflects routine equity-based compensation and does not represent a discretionary market trade.
BENCHIMOL ALBERT reported acquisition or exercise transactions in this Form 4 filing.
AEGON LTD. director Albert Benchimol received an award of 32 Common Shares on 2026-07-06 at a price of $0.00 per share. This was a grant of dividend equivalent shares tied to his outstanding equity awards and is compensation-related rather than an open-market trade. Following this award, he directly holds 15,705 Common Shares.
Ramsay Caroline Frances reported acquisition or exercise transactions in this Form 4 filing.
AEGON LTD. director Caroline Frances Ramsay received an award of 32 Common Shares on 2026-07-06 as dividend equivalent shares tied to her outstanding equity awards. These compensation-related shares were granted at no cash cost, bringing her direct holdings to 10,709 Common Shares after the transaction.
Aegon has begun a new EUR 200 million share buyback, announced at its Capital Markets Day in December 2025, which it expects to complete by December 23, 2026. The company plans to cancel the repurchased shares.
Vereniging Aegon, holding about 18.4% of shareholders’ voting rights, will participate pro rata for EUR 37 million. Aegon also completed a separate EUR 227 million buyback that ran from January 12, 2026 to June 30, 2026, repurchasing 33,909,553 shares at an average price of EUR 6.68. Of these, 4,033,295 shares (worth EUR 27 million) will be used for senior management share-based compensation, and the remainder will be cancelled in the second half of 2026.
Boeren Leni reported acquisition or exercise transactions in this Form 4 filing.
AEGON LTD. director Leni Boeren received a grant of 4,160 Common Shares on June 10, 2026 as equity compensation. The shares were awarded at a price of $0.00 per share and are subject to time-based vesting under the applicable grant agreement. After this grant, Boeren directly holds 4,160 Common Shares.
AEGON LTD. filed an initial insider ownership report for director Leni Boeren. This Form 3 establishes Boeren as a reporting insider of the company but does not list any stock holdings or transactions at this time.
Aegon is reorganizing senior leadership and selecting New York City as its future corporate headquarters as part of a planned move of its head office and legal seat to the United States. Will Fuller will be appointed President and Chief Operating Officer effective January 1, 2027, responsible for day-to-day management of Transamerica, Aegon’s International businesses and Aegon Asset Management, and will report to CEO Lard Friese. Mr. Friese will relocate to the United States at the beginning of 2027. Aegon says the New York office is expected to open in mid-2027 and will house selected corporate functions and members of the leadership team. The communication reiterates that Aegon will file a registration statement on Form F-4 and mail a definitive Proxy Statement/Prospectus ahead of an extraordinary general meeting contemplated in Q4 2026 in connection with the proposed Redomiciliation.
Aegon Ltd is reshaping its leadership and corporate structure as it prepares to redomicile to the United States and establish a new headquarters. The company will appoint Will Fuller as President and Chief Operating Officer effective January 1, 2027, putting him in charge of Transamerica, Aegon’s International businesses, and Aegon Asset Management while he reports to CEO Lard Friese. Friese will remain CEO with full responsibility for group strategy and performance and plans to relocate to the United States at the beginning of 2027. Aegon has also chosen New York City as the location for its future corporate headquarters, with an office expected to open in mid-2027 to host key corporate functions and leadership. As part of a broader corporate reorganization, Aegon intends to file a Form F-4 registration statement with the SEC that will include a Proxy Statement/Prospectus for shareholders, with an extraordinary general meeting on the proposed redomiciliation contemplated for Q4 2026.
Aegon Ltd. reports that its Annual General Meeting of Shareholders approved all items on the agenda. Shareholders approved a final dividend for 2025 of EUR 0.21 per common share, bringing the total 2025 dividend to EUR 0.40 per common share.
The meeting also approved extending Lard Friese’s term as Executive Director and Chief Executive Officer until the end of the 2030 AGM and appointed Leni Boeren to the Board of Directors. The company reiterates standard forward-looking statement cautions and provides links to full AGM resolution details on its website.
Vereniging Aegon filed an amended Schedule 13D showing beneficial ownership of 265,681,483 Aegon Ltd. common shares, representing 17.92% of the class, based on 1,482,375,744 shares outstanding as of May 27, 2026.
The filing describes a Framework Agreement between Vereniging Aegon and Aegon Ltd. Under this agreement, Vereniging Aegon will transfer EUR 500 million and certain charity agreements and interests to a new Dutch charitable foundation in a transaction referred to as the “VA Split.” The VA Split will not involve any disposition of Aegon common shares and, after it is completed, Vereniging Aegon will be renamed “Vereniging Aegon Americas.”
In addition to the common shares reported, Vereniging Aegon has sole power to vote and dispose of 327,885,200 Common Shares B. When combined with its common shares, this gives Vereniging Aegon the power to vote 32.64% of Aegon Ltd.’s total voting power.